Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

17.15
Delayed Data
As of Dec 05
 +0.49 / +2.94%
Today’s Change
15.92
Today|||52-Week Range
44.57
-60.26%
Year-to-Date

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 18.00, with a high estimate of 42.00 and a low estimate of 16.00. The median estimate represents a +4.96% increase from the last price of 17.15.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.24
Sales
$189.3M
Reporting Date
Feb 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.74%
 
 
 
 
 
 
Growthannually -37.50%
 
 
 
 
 
 

Sales

Growthquarterly 6.64%
 
 
 
 
 
 
Growthannually -0.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.